Management of life-threatening acid-base disorders. Second of two parts.
about
The meaning of acid-base abnormalities in the intensive care unit: part III -- effects of fluid administrationAmmonia transport in the kidney by Rhesus glycoproteins.Acidosis and tissue hypoxia in the critically ill: how to measure it and what does it mean.Maintaining acid-base balance in organ donors.Metabolic alkalosis in the intensive care unit.Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs.Blood lactate levels in patients receiving first- or second- generation antipsychotics.Injectable ammonium chloride used enterally for the treatment of persistent metabolic alkalosis in three pediatric patientsDiagnosis and treatment of simple acid-base disorders.Extreme Metabolic Alkalosis Caused by Gastrostomy Tube Malposition Treated Using Conventional Hemodialysis.Prognosis of alcohol-associated lactic acidosis in critically ill patients: an 8-year study.Simple acid-base tutorial.Acid-base disturbances in intensive care patients: etiology, pathophysiology and treatment.T1 nuclear magnetic relaxation dispersion of hyperpolarized sodium and cesium hydrogencarbonate-13 C.Acetazolamide in critically ill neonates and children with metabolic alkalosis.Respiratory clinics ventilatory management in a patient with chronic obstructive pulmonary disease: a need for cautionSerum alkalinization and hydrogen-rich water in healthy men.Severe lactic acidosis following alcohol related generalised seizures.An arginine residue in the pore region is a key determinant of chloride dependence in cardiac pacemaker channels.Mathematical modeling of buffers used in myocardial preservation.Mechanical ventilation strategies alter cardiovascular biomarkers in an infant rat model.Changes of serum chloride and metabolic acid-base state in critical illness.Understanding Acid-Base Disorders.Use of Arginine Hydrochloride in the Treatment of Metabolic Alkalosis or Hypochloremia in Pediatric Patients.
P2860
Q24811937-E640883E-D9EA-4C2F-8E2D-8D01079F8BDBQ30578351-9EBD9A51-D813-46C4-BEB7-D47CE68A25BFQ33545585-95497B89-15EE-4BB7-8C39-1E4556FC4861Q33996401-E9803430-C484-416B-86D0-F839069FF782Q34221864-DBC9F4E5-3B9F-42D1-9116-F5B2C07A017CQ34551966-45214A9E-D9C4-48FF-B21B-7615BBB7FBD6Q34613859-BF8163B1-ACD6-4C67-8ACF-44C2633320F8Q36191107-7AF5E242-2B7A-427A-9F4F-5517B676A63EQ37129221-AC1B4AB1-AE67-4966-97A7-A4BE00DDB79EQ37293339-0260031B-3677-4F73-A392-9A4E016938CCQ37343171-045F7A24-E112-4943-86B6-92DFE0CFF192Q37969627-05BA1644-D87A-4041-BAAD-C8DB74A937ADQ38248519-9BC81DD6-4D24-4D8F-AA84-675B1B8C2A1AQ38707574-F0DCC970-74C7-4532-9093-13F17C898326Q39310922-ADB6FCC5-3AB5-4CF9-BA01-BB5D12447581Q42244607-5D686A94-70CC-493E-89DF-A13F026FD3D3Q42336415-4868124D-2497-400C-AEFB-A81966589A60Q45154401-421C4499-F98B-4261-AA52-E7B90322ADD6Q45219843-A893EEB3-80F1-4EE3-ACD8-F1FD3F4E798AQ46641821-A00F2EFC-8EE3-4E41-B822-E3794ACEAEDFQ48143031-CA81183A-2367-4FB7-A0F1-18E4E000C17BQ48833559-14590C78-4056-4BCB-94E1-BA5D60FEE517Q55155613-9CCDEAC4-56EB-45D9-9E4D-0C33D9E569CAQ55208226-4FED4920-5856-42EA-9A76-1FBF3205C76E
P2860
Management of life-threatening acid-base disorders. Second of two parts.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Management of life-threatening acid-base disorders. Second of two parts.
@en
type
label
Management of life-threatening acid-base disorders. Second of two parts.
@en
prefLabel
Management of life-threatening acid-base disorders. Second of two parts.
@en
P1476
Management of life-threatening acid-base disorders. Second of two parts.
@en
P2093
P304
P356
10.1056/NEJM199801083380207
P407
P577
1998-01-01T00:00:00Z